MRI for identification of progression in brain tumors: from morphology to function
暂无分享,去创建一个
[1] J D Pickard,et al. Diffusion tensor imaging of brain tumours at 3T: a potential tool for assessing white matter tract invasion? , 2003, Clinical radiology.
[2] Stephan E Maier,et al. Early detection of response to radiation therapy in patients with brain malignancies using conventional and high b-value diffusion-weighted magnetic resonance imaging. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] B Stieltjes,et al. Detection of tumour infiltration in axonal fibre bundles using diffusion tensor imaging , 2005, The international journal of medical robotics + computer assisted surgery : MRCAS.
[4] Tristan Barrett,et al. MRI of tumor angiogenesis , 2007, Journal of magnetic resonance imaging : JMRI.
[5] P Bachert,et al. Proton MR spectroscopic evaluation of suspicious brain lesions after stereotactic radiotherapy. , 2001, AJNR. American journal of neuroradiology.
[6] M. Essig,et al. MR-Perfusions- und spektroskopische Bildgebung bei WHO-Grad-II-Astrozytomen , 2007, Der Radiologe.
[7] F. Giangaspero. Emerging Tumor Entities and Variants of CNS Neoplasms , 2004, Journal of neuropathology and experimental neurology.
[8] V. Tronnier,et al. Distinguishing of primary cerebral lymphoma from high-grade glioma with perfusion-weighted magnetic resonance imaging , 2003, Neuroscience Letters.
[9] L. Calabi,et al. Gadobenate dimeglumine 0.5 M solution for injection (MultiHance) pharmaceutical formulation and physicochemical properties of a new magnetic resonance imaging contrast medium. , 1999, Journal of computer assisted tomography.
[10] C. Kuhl,et al. Brain tumors: full- and half-dose contrast-enhanced MR imaging at 3.0 T compared with 1.5 T--Initial Experience. , 2005, Radiology.
[11] G Brix,et al. Pathophysiologic basis of contrast enhancement in breast tumors , 1999, Journal of magnetic resonance imaging : JMRI.
[12] P. Black,et al. Epidemiology of intracranial meningioma. , 2005, Neurosurgery.
[13] J. Voges,et al. Imaging in Gene Therapy of Patients with Glioma , 2003, Journal of Neuro-Oncology.
[14] B. Rosen,et al. Early changes measured by magnetic resonance imaging in cerebral blood flow, blood volume, and blood-brain barrier permeability following dexamethasone treatment in patients with brain tumors. , 1999, Journal of neurosurgery.
[15] M V Knopp,et al. Dynamic contrast-enhanced magnetic resonance imaging in oncology. , 2001, Topics in magnetic resonance imaging : TMRI.
[16] Bjoern H Menze,et al. Optimal classification of long echo time in vivo magnetic resonance spectra in the detection of recurrent brain tumors , 2006, NMR in biomedicine.
[17] J. Debus,et al. Monitoring individual response to brain-tumour chemotherapy: proton MR spectroscopy in a patient with recurrent glioma after stereotactic radiotherapy , 2004, Neuroradiology.
[18] P. Tofts,et al. Measurement of the blood‐brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts , 1991, Magnetic resonance in medicine.
[19] Mauricio Castillo,et al. MR spectroscopy of brain tumors. , 2003, Magnetic resonance imaging clinics of North America.
[20] Bradford A Moffat,et al. The functional diffusion map: an imaging biomarker for the early prediction of cancer treatment outcome. , 2006, Neoplasia.
[21] P. Kleihues,et al. Primary and secondary glioblastomas: from concept to clinical diagnosis. , 1999, Neuro-oncology.
[22] M. Décorps,et al. Methodology of brain perfusion imaging , 2001, Journal of magnetic resonance imaging : JMRI.
[23] Marc-André Weber,et al. Mimicking the human expert: Pattern recognition for an automated assessment of data quality in MR spectroscopic images , 2008, Magnetic resonance in medicine.
[24] Michael Bock,et al. 3D radial projection technique with ultrashort echo times for sodium MRI: Clinical applications in human brain and skeletal muscle , 2007, Magnetic resonance in medicine.
[25] M P Lichy,et al. Diagnostic performance of spectroscopic and perfusion MRI for distinction of brain tumors , 2006, Neurology.
[26] G. Fuller,et al. The significance of lack of MR contrast enhancement of supratentorial brain tumors in adults: histopathological evaluation of a series. , 1998, Surgical neurology.
[27] Elias R Melhem,et al. Intraaxial brain masses: MR imaging-based diagnostic strategy--initial experience. , 2007, Radiology.
[28] Mark E Mullins,et al. Radiation necrosis versus glioma recurrence: conventional MR imaging clues to diagnosis. , 2005, AJNR. American journal of neuroradiology.
[29] J Debus,et al. Assessment of brain metastases with dynamic susceptibility-weighted contrast-enhanced MR imaging: initial results. , 2003, Radiology.
[30] S. Cherry,et al. Simultaneous in vivo positron emission tomography and magnetic resonance imaging , 2008, Proceedings of the National Academy of Sciences of the United States of America.
[31] N. Hopf,et al. Contribution of diffusion tensor imaging to delineation of gliomas and glioblastomas , 2004, Journal of magnetic resonance imaging : JMRI.
[32] Marc-André Weber,et al. Semi-supervised Tumor Detection in Magnetic Resonance Spectroscopic Images Using Discriminative Random Fields , 2007, DAGM-Symposium.
[33] I. Wilkinson,et al. Influence of Human Serum Albumin on Longitudinal and Transverse Relaxation Rates (R1 and R2) of Magnetic Resonance Contrast Agents , 2006, Investigative radiology.
[34] Daniel P Barboriak,et al. Diffusion-weighted and perfusion MR imaging for brain tumor characterization and assessment of treatment response. , 2006, Radiology.
[35] Xavier Golay,et al. Amide proton transfer imaging of human brain tumors at 3T , 2006, Magnetic resonance in medicine.
[36] M E Moseley,et al. New magnetic resonance imaging methods for cerebrovascular disease: Emerging clinical applications , 2000, Annals of neurology.
[37] L D Lunsford,et al. Unreliability of contemporary neurodiagnostic imaging in evaluating suspected adult supratentorial (low-grade) astrocytoma. , 1993, Journal of neurosurgery.
[38] Robert C Brasch,et al. Dynamic contrast‐enhanced magnetic resonance imaging as a surrogate marker of tumor response to anti‐angiogenic therapy in a xenograft model of glioblastoma multiforme , 2002, Journal of magnetic resonance imaging : JMRI.
[39] M. Bock,et al. Assessment of Gadobenate Dimeglumine for Magnetic Resonance Angiography: Phase I Studies , 2002, Investigative radiology.
[40] B A Kall,et al. Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms. , 1987, Journal of neurosurgery.
[41] R. Ouwerkerk. Sodium magnetic resonance imaging: from research to clinical use. , 2007, Journal of the American College of Radiology : JACR.
[42] T. Koepsell,et al. Epidemiology of intracranial meningioma , 1993, Cancer.
[43] W. Heiss,et al. Molecular Imaging of Gliomas , 2002, Molecular imaging.
[44] I. Wilkinson,et al. Dexamethasone and Enhancing Solitary Cerebral Mass Lesions: Alterations in Perfusion and Blood-tumor Barrier Kinetics Shown by Magnetic Resonance Imaging , 2006, Neurosurgery.
[45] C. Beaulieu,et al. Determinants of anisotropic water diffusion in nerves , 1994, Magnetic resonance in medicine.
[46] M. Leach,et al. Monitoring temozolomide treatment of low-grade glioma with proton magnetic resonance spectroscopy , 2004, British Journal of Cancer.
[47] Frederik L. Giesel,et al. Diagnostic performance of spectroscopic and perfusion MRI for distinction of brain tumors , 2006, Neurology.
[48] K. Zierler,et al. On the theory of the indicator-dilution method for measurement of blood flow and volume. , 1954, Journal of applied physiology.
[49] G Johnson,et al. Dynamic contrast-enhanced T2-weighted MR imaging of recurrent malignant gliomas treated with thalidomide and carboplatin. , 2000, AJNR. American journal of neuroradiology.
[50] F. Cavagna,et al. Gd‐BOPTA/Dimeg: Experimental disease imaging , 1991, Magnetic resonance in medicine.
[51] Peter McGraw,et al. Peritumoral brain regions in gliomas and meningiomas: investigation with isotropic diffusion-weighted MR imaging and diffusion-tensor MR imaging. , 2004, Radiology.
[52] A. Padhani. Dynamic contrast‐enhanced MRI in clinical oncology: Current status and future directions , 2002, Journal of magnetic resonance imaging : JMRI.
[53] Matthias Günther,et al. Comparison of Arterial Spin-Labeling Techniques and Dynamic Susceptibility-Weighted Contrast-Enhanced MRI in Perfusion Imaging of Normal Brain Tissue , 2003, Investigative radiology.
[54] K. Herfarth,et al. PET and SPECT for detection of tumor progression in irradiated low-grade astrocytoma: a receiver-operating-characteristic analysis. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[55] H. Minn. PET and SPECT in low-grade glioma. , 2005, European journal of radiology.
[56] J. Dichgans,et al. One week on/one week off: A novel active regimen of temozolomide for recurrent glioblastoma , 2004, Neurology.
[57] James M Provenzale,et al. Lymphomas and high-grade astrocytomas: comparison of water diffusibility and histologic characteristics. , 2002, Radiology.
[58] Heinz-Otto Peitgen,et al. Diffusion tensor imaging in primary brain tumors: Reproducible quantitative analysis of corpus callosum infiltration and contralateral involvement using a probabilistic mixture model , 2006, NeuroImage.
[59] Thomas L Chenevert,et al. Diffusion imaging: insight to cell status and cytoarchitecture. , 2006, Neuroimaging clinics of North America.
[60] M. Maeda,et al. Double-echo perfusion-weighted MR imaging: basic concepts and application in brain tumors for the assessment of tumor blood volume and vascular permeability , 2005, European Radiology.
[61] J. O'fallon,et al. Triple-dose Contrast/magnetization Transfer Suppressed Imaging of ‘non-enhancing’ Brain Gliomas , 2002, Journal of Neuro-Oncology.
[62] V. Stieber. Low-grade gliomas , 2001, Current Treatment Options in Oncology.
[63] M. Knopp,et al. Functional tumor imaging with dynamic contrast‐enhanced magnetic resonance imaging , 2003, Journal of magnetic resonance imaging : JMRI.
[64] L R Schad,et al. Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging. , 1991, Journal of computer assisted tomography.
[65] H. Kauczor,et al. Dynamic contrast-enhanced MRI of malignant pleural mesothelioma: a feasibility study of noninvasive assessment, therapeutic follow-up, and possible predictor of improved outcome. , 2006, Chest.
[66] B. Hiremagalur,et al. Gadolinium and nephrogenic systemic fibrosis: Association or causation (Review Article) , 2008, Nephrology.
[67] W. Yuh,et al. Contrast-Enhanced Magnetic Resonance Imaging of Central Nervous System Tumors: Agents, Mechanisms, and Applications , 2006, Topics in magnetic resonance imaging : TMRI.
[68] C. Colosimo,et al. Detection of Intracranial Metastases: A Multicenter, Intrapatient Comparison of Gadobenate Dimeglumine-Enhanced MRI with Routinely Used Contrast Agents at Equal Dosage , 2001, Investigative radiology.
[69] J. E. Tanner,et al. Spin diffusion measurements : spin echoes in the presence of a time-dependent field gradient , 1965 .
[70] C. Zimmer,et al. Quantification of blood flow in brain tumors: comparison of arterial spin labeling and dynamic susceptibility-weighted contrast-enhanced MR imaging. , 2003, Radiology.
[71] Glyn Johnson,et al. Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging. , 2002, Radiology.
[72] P. Kirchner,et al. Diagnosis of recurrent brain tumor: value of 201Tl SPECT vs 18F-fluorodeoxyglucose PET. , 1994, AJR. American journal of roentgenology.
[73] G Brix,et al. Pharmacokinetic MRI for assessment of malignant glioma response to stereotactic radiotherapy: Initial results , 1998, Journal of magnetic resonance imaging : JMRI.
[74] C. Eskey,et al. Diffusion-weighted imaging in the follow-up of treated high-grade gliomas: tumor recurrence versus radiation injury. , 2004, AJNR. American journal of neuroradiology.
[75] Glyn Johnson,et al. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. , 2003, AJNR. American journal of neuroradiology.
[76] Heinz-Peter Schlemmer,et al. Follow-up gliomas after radiotherapy: 1H MR spectroscopic imaging for increasing diagnostic accuracy , 2005, Neuroradiology.
[77] S. Delorme,et al. Applications of MRS in the evaluation of focal malignant brain lesions , 2006, Cancer imaging : the official publication of the International Cancer Imaging Society.
[78] A. Walker,et al. Epidemiology of brain tumors , 1985, Neurology.
[79] M. Essig,et al. Tumor angiogenesis of low-grade astrocytomas measured by dynamic susceptibility contrast-enhanced MRI (DSC-MRI) is predictive of local tumor control after radiation therapy. , 2001, International journal of radiation oncology, biology, physics.
[80] P. Kleihues,et al. Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. , 2005, Journal of neuropathology and experimental neurology.
[81] M P Lichy,et al. [Application of (1)H MR spectroscopic imaging in radiation oncology: choline as a marker for determining the relative probability of tumor progression after radiation of glial brain tumors]. , 2006, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.
[82] W. Heiss,et al. Imaging-guided gene therapy of experimental gliomas. , 2007, Cancer research.
[83] Glyn Johnson,et al. Low-grade gliomas: dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging--prediction of patient clinical response. , 2006, Radiology.
[84] G. Morana,et al. Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study. , 2005, Radiology.
[85] U. Haberkorn,et al. PET imaging of somatostatin receptors using [68GA]DOTA-D-Phe1-Tyr3-octreotide: first results in patients with meningiomas. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[86] M Takahashi,et al. Posttherapeutic intraaxial brain tumor: the value of perfusion-sensitive contrast-enhanced MR imaging for differentiating tumor recurrence from nonneoplastic contrast-enhancing tissue. , 2000, AJNR. American journal of neuroradiology.
[87] G Brix,et al. An optimized workflow for the integration of biological information into radiotherapy planning: experiences with T1w DCE-MRI , 2005, Physics in medicine and biology.
[88] Soonmee Cha,et al. Perfusion MR Imaging of Brain Tumors , 2004, Topics in magnetic resonance imaging : TMRI.
[89] K. Herfarth,et al. Detection of tumour progression in the follow-up of irradiated low-grade astrocytomas: comparison of 3-[123I]iodo-α-methyl-L-tyrosine and 99mTc-MIBI SPET , 2002, European Journal of Nuclear Medicine and Molecular Imaging.
[90] J. Debatin,et al. Gadobenate dimeglumine (MultiHance®) for magnetic resonance angiography: review of literature , 2003, European Radiology.
[91] M. Knopp,et al. Primary and secondary brain tumors at MR imaging: bicentric intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine. , 2004, Radiology.
[92] H. Kauczor,et al. Assessment of Irradiated Brain Metastases by Means of Arterial Spin-Labeling and Dynamic Susceptibility-Weighted Contrast-Enhanced Perfusion MRI: Initial Results , 2004, Investigative radiology.
[93] R. Strecker,et al. Vessel size imaging in humans , 2005, Magnetic resonance in medicine.
[94] M. Knopp,et al. Intracranial meningeomas: time- and dose-dependent effects of irradiation on tumor microcirculation monitored by dynamic MR imaging. , 1997, Magnetic resonance imaging.
[95] Michael H Lev,et al. Dynamic magnetic resonance perfusion imaging of brain tumors. , 2004, The oncologist.
[96] W. Yuh,et al. The effect of contrast dose, imaging time, and lesion size in the MR detection of intracerebral metastasis. , 1995, AJNR. American journal of neuroradiology.
[97] K. Ohata,et al. Methionine positron emission tomography of recurrent metastatic brain tumor and radiation necrosis after stereotactic radiosurgery: is a differential diagnosis possible? , 2003, Journal of neurosurgery.
[98] G. Pearlson,et al. Diffusion Tensor Imaging and Axonal Tracking in the Human Brainstem , 2001, NeuroImage.
[99] M. Bastin,et al. Effects of dexamethasone on peritumoural oedematous brain: a DT-MRI study , 2004, Journal of Neurology, Neurosurgery & Psychiatry.
[100] C. Plathow,et al. Metabolische Bildgebung zur Verlaufskontrolle stereotaktisch bestrahlter Gliome: Wertigkeit der 1H-MR-Spektroskopie im Vergleich zur FDG-PET und IMT-SPECT , 2004 .
[101] N. Hylton. Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.